57/100B423.40
USD
-5.65
(-1.31%)
Market Open
Last updated: · Delayed 15 min
Fair value401.93Plus+5%262Price 423.40501
Q4 FY2026 · Earnings report
EPS estimate 2.08Revenue estimate 49.38B
Q4 FY2026 · Earnings report
EPS estimate 2.08Revenue estimate 49.38B
Elevance Health cash on hand 1998–2026What is a balance sheet? The balance sheet lists what a company owns (assets), what it owes (liabilities) and what is left for its shareholders (equity) on one date.
Elevance Health had 37.85B USD in cash and short-term investments on 30 September 2026, up 334.4% on a year before. At the end of fiscal year 2025 it had 9.49B USD.
Last updated 12 Nov 2026 · Next report 27 Jan 2027
Cash on hand
Growth
| Fiscal year | Period ending | Cash on hand | Growth | Total debt | Net cash |
|---|---|---|---|---|---|
| Latest quarter | 30 Sept 2026 | 37.85B | +334.36% | 30.76B | 7.09B |
| FY2025 | 31 Dec 2025 | 9.49B | +14.51% | 33.24B | -23.74B |
| FY2024 | 31 Dec 2024 | 8.29B | +27.00% | 32.70B | -24.41B |
| FY2023 | 31 Dec 2023 | 6.53B | -11.66% | 26.65B | -20.13B |
| FY2022 | 31 Dec 2022 | 7.39B | +51.37% | 25.80B | -18.41B |
| FY2021 | 31 Dec 2021 | 4.88B | -15.00% | 24.89B | -20.01B |
| FY2020 | 31 Dec 2020 | 5.74B | +16.29% | 21.84B | -16.10B |
| FY2019 | 31 Dec 2019 | 4.94B | +25.50% | 21.21B | -16.27B |
| FY2018 | 31 Dec 2018 | 3.93B | +9.01% | 19.21B | -15.28B |
| FY2017 | 31 Dec 2017 | 3.61B | -11.44% | 19.93B | -16.32B |
| FY2016 | 31 Dec 2016 | 4.08B | +92.82% | 15.73B | -11.65B |
| FY2015 | 31 Dec 2015 | 2.11B | -1.78% | 15.86B | -13.75B |
| FY2014 | 31 Dec 2014 | 2.15B | +36.00% | 15.04B | -12.89B |
| FY2013 | 31 Dec 2013 | 1.58B | -36.08% | 14.49B | -12.91B |
| FY2012 | 31 Dec 2012 | 2.48B | +12.43% | 14.98B | -12.50B |
| FY2011 | 31 Dec 2011 | 2.20B | +23.08% | 9.84B | -7.64B |
| FY2010 | 31 Dec 2010 | 1.79B | -62.86% | 8.95B | -7.16B |
| FY2009 | 31 Dec 2009 | 4.82B | +120.53% | 8.40B | -3.58B |
| FY2008 | 31 Dec 2008 | 2.18B | -21.10% | 8.84B | -6.66B |
| FY2007 | 31 Dec 2007 | 2.77B | +6.37% | 9.04B | -6.28B |
| FY2006 | 31 Dec 2006 | 2.60B | -5.04% | 7.01B | -4.41B |
| FY2005 | 31 Dec 2005 | 2.74B | +88.05% | 6.81B | -4.07B |
| FY2004 | 31 Dec 2004 | 1.46B | -80.25% | 4.43B | -2.97B |
| FY2003 | 31 Dec 2003 | 7.38B | +11.09% | 2.06B | 5.32B |
| FY2002 | 31 Dec 2002 | 6.64B | +48.34% | 1.66B | 4.98B |
| FY2001 | 31 Dec 2001 | 4.48B | — | 1.13B | 3.35B |
| FY2000 | 31 Dec 2000 | 0.00 | — | 597.50M | -597.50M |
| FY1999 | 31 Dec 1999 | 0.00 | — | 522.00M | -522.00M |
| FY1998 | 31 Dec 1998 | 0.00 | — | 301.90M | -301.90M |
| Quarter | Period ending | Cash on hand | Growth on a year before | Total debt | Net cash |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 37.85B | +334.36% | 30.76B | 7.09B |
| Q2 FY2026 | 30 Jun 2026 | 37.51B | +338.25% | 31.04B | 6.47B |
| Q1 FY2026 | 31 Mar 2026 | 35.56B | +374.16% | 31.84B | 3.72B |
| Q4 FY2025 | 31 Dec 2025 | 9.49B | +14.51% | 33.24B | -23.74B |
| Q3 FY2025 | 30 Sept 2025 | 8.71B | +10.77% | 32.10B | -23.39B |
| Q2 FY2025 | 30 Jun 2025 | 8.56B | +31.75% | 30.19B | -21.63B |
| Q1 FY2025 | 31 Mar 2025 | 7.50B | +20.46% | 30.00B | -22.50B |
| Q4 FY2024 | 31 Dec 2024 | 8.29B | +27.00% | 32.70B | -24.41B |
| Q3 FY2024 | 30 Sept 2024 | 7.87B | -27.96% | 27.15B | -19.28B |
| Q2 FY2024 | 30 Jun 2024 | 6.50B | -34.97% | 27.69B | -21.19B |
| Q1 FY2024 | 31 Mar 2024 | 6.23B | -38.61% | 26.45B | -20.23B |
| Q4 FY2023 | 31 Dec 2023 | 6.53B | -11.66% | 26.65B | -20.13B |
| Q3 FY2023 | 30 Sept 2023 | 10.92B | +23.07% | 26.41B | -15.49B |
| Q2 FY2023 | 30 Jun 2023 | 9.99B | +54.76% | 26.74B | -16.75B |
| Q1 FY2023 | 31 Mar 2023 | 10.14B | +64.62% | 27.10B | -16.96B |
| Q4 FY2022 | 31 Dec 2022 | 7.39B | +51.37% | 25.80B | -18.41B |
| Q3 FY2022 | 30 Sept 2022 | 8.87B | +61.60% | 25.43B | -16.56B |
| Q2 FY2022 | 30 Jun 2022 | 6.46B | +22.78% | 25.24B | -18.79B |
| Q1 FY2022 | 31 Mar 2022 | 6.16B | -33.94% | 25.00B | -18.84B |
| Q4 FY2021 | 31 Dec 2021 | 4.88B | -15.00% | 24.89B | -20.01B |
| Q3 FY2021 | 30 Sept 2021 | 5.49B | +37.80% | 24.54B | -19.05B |
| Q2 FY2021 | 30 Jun 2021 | 5.26B | -12.77% | 25.05B | -19.79B |
| Q1 FY2021 | 31 Mar 2021 | 9.33B | +74.48% | 24.95B | -15.63B |
| Q4 FY2020 | 31 Dec 2020 | 5.74B | +16.29% | 21.84B | -16.10B |
| Q3 FY2020 | 30 Sept 2020 | 3.98B | -4.92% | 22.63B | -18.65B |
| Q2 FY2020 | 30 Jun 2020 | 6.03B | +47.82% | 23.30B | -17.27B |
| Q1 FY2020 | 31 Mar 2020 | 5.35B | +19.25% | 23.48B | -18.14B |
| Q4 FY2019 | 31 Dec 2019 | 4.94B | +25.50% | 21.21B | -16.27B |
| Q3 FY2019 | 30 Sept 2019 | 4.19B | -1.64% | 21.34B | -17.15B |
| Q2 FY2019 | 30 Jun 2019 | 4.08B | -12.90% | 20.52B | -16.44B |
| Q1 FY2019 | 31 Mar 2019 | 4.48B | -3.21% | 20.56B | -16.07B |
| Q4 FY2018 | 31 Dec 2018 | 3.93B | +9.01% | 19.21B | -15.28B |
| Q3 FY2018 | 30 Sept 2018 | 4.26B | -30.13% | 19.42B | -15.16B |
| Q2 FY2018 | 30 Jun 2018 | 4.68B | +2.65% | 19.29B | -14.60B |
| Q1 FY2018 | 31 Mar 2018 | 4.63B | -31.63% | 19.89B | -15.26B |
| Q4 FY2017 | 31 Dec 2017 | 3.61B | -84.12% | 19.93B | -16.32B |
| Q3 FY2017 | 30 Sept 2017 | 6.10B | -72.61% | 16.23B | -10.13B |
| Q2 FY2017 | 30 Jun 2017 | 4.56B | -77.38% | 16.29B | -11.73B |
| Q1 FY2017 | 31 Mar 2017 | 6.77B | -66.22% | 17.14B | -10.37B |
| Q4 FY2016 | 31 Dec 2016 | 22.72B | +19.26% | 15.73B | 7.00B |
| Q3 FY2016 | 30 Sept 2016 | 22.26B | +14.36% | 15.61B | 6.65B |
| Q2 FY2016 | 30 Jun 2016 | 20.16B | +1.78% | 15.57B | 4.59B |
| Q1 FY2016 | 31 Mar 2016 | 20.05B | -0.87% | 15.80B | 4.25B |
| Q4 FY2015 | 31 Dec 2015 | 19.05B | -2.99% | 15.86B | 3.19B |
| Q3 FY2015 | 30 Sept 2015 | 19.46B | -2.79% | 16.26B | 3.20B |
| Q2 FY2015 | 30 Jun 2015 | 19.81B | -1.61% | 16.63B | 3.18B |
| Q1 FY2015 | 31 Mar 2015 | 20.23B | +1.13% | 15.84B | 4.39B |
| Q4 FY2014 | 31 Dec 2014 | 19.64B | +5.38% | 15.04B | 4.60B |
| Q3 FY2014 | 30 Sept 2014 | 20.02B | +1.43% | 15.26B | 4.76B |
| Q2 FY2014 | 30 Jun 2014 | 20.14B | +5.75% | 14.80B | 5.34B |
| Q1 FY2014 | 31 Mar 2014 | 20.00B | +2.56% | 15.04B | 4.96B |
| Q4 FY2013 | 31 Dec 2013 | 18.64B | -3.95% | 14.49B | 4.15B |
| Q3 FY2013 | 30 Sept 2013 | 19.74B | -10.81% | 14.86B | 4.87B |
| Q2 FY2013 | 30 Jun 2013 | 19.04B | -6.26% | 14.84B | 4.20B |
| Q1 FY2013 | 31 Mar 2013 | 19.50B | -1.12% | 14.78B | 4.72B |
| Q4 FY2012 | 31 Dec 2012 | 19.40B | +7.02% | 14.98B | 4.43B |
| Q3 FY2012 | 30 Sept 2012 | 22.13B | +9.74% | 13.59B | 8.54B |
| Q2 FY2012 | 30 Jun 2012 | 20.31B | +3.86% | 11.15B | 9.17B |
| Q1 FY2012 | 31 Mar 2012 | 19.72B | +0.91% | 9.47B | 10.25B |
| Q4 FY2011 | 31 Dec 2011 | 18.13B | -5.16% | 9.84B | 8.29B |
| Q3 FY2011 | 30 Sept 2011 | 20.17B | +797.89% | 10.00B | 10.17B |
| Q2 FY2011 | 30 Jun 2011 | 19.56B | +864.49% | 8.85B | 10.71B |
| Q1 FY2011 | 31 Mar 2011 | 19.54B | +454.22% | 9.00B | 10.54B |
| Q4 FY2010 | 31 Dec 2010 | 19.12B | -11.30% | 8.95B | 10.16B |
| Q3 FY2010 | 30 Sept 2010 | 2.25B | +21.93% | 9.02B | -6.78B |
| Q2 FY2010 | 30 Jun 2010 | 2.03B | +17.59% | 8.55B | -6.52B |
| Q1 FY2010 | 31 Mar 2010 | 3.53B | +48.28% | 8.39B | -4.86B |
| Q4 FY2009 | 31 Dec 2009 | 21.55B | +886.78% | 8.40B | 13.15B |
| Q3 FY2009 | 30 Sept 2009 | 1.84B | -18.87% | 8.86B | -7.02B |
| Q2 FY2009 | 30 Jun 2009 | 1.72B | -70.34% | 9.17B | -7.45B |
| Q1 FY2009 | 31 Mar 2009 | 2.38B | -62.62% | 9.34B | -6.96B |
| Q4 FY2008 | 31 Dec 2008 | 2.18B | -66.37% | 8.84B | -6.66B |
| Q3 FY2008 | 30 Sept 2008 | 2.27B | -66.37% | 9.22B | -6.94B |
| Q2 FY2008 | 30 Jun 2008 | 5.82B | -27.12% | 9.77B | -3.95B |
| Q1 FY2008 | 31 Mar 2008 | 6.36B | -10.82% | 9.29B | -2.92B |
| Q4 FY2007 | 31 Dec 2007 | 6.49B | +28.55% | 9.04B | -2.55B |
| Q3 FY2007 | 30 Sept 2007 | 6.75B | +49.88% | 8.70B | -1.95B |
| Q2 FY2007 | 30 Jun 2007 | 7.98B | +103.72% | 8.17B | -193.30M |
| Q1 FY2007 | 31 Mar 2007 | 7.13B | +68.45% | 7.11B | 27.20M |
| Q4 FY2006 | 31 Dec 2006 | 5.05B | -74.12% | 7.01B | -1.96B |
| Q3 FY2006 | 30 Sept 2006 | 4.50B | -73.10% | 7.34B | -2.84B |
| Q2 FY2006 | 30 Jun 2006 | 3.92B | -76.43% | 7.47B | -3.55B |
| Q1 FY2006 | 31 Mar 2006 | 4.24B | -73.14% | 7.14B | -2.91B |
| Q4 FY2005 | 31 Dec 2005 | 19.52B | +29.76% | 6.81B | 12.71B |
| Q3 FY2005 | 30 Sept 2005 | 16.74B | +110.66% | 4.38B | 12.37B |
| Q2 FY2005 | 30 Jun 2005 | 16.62B | +120.60% | 4.62B | 11.99B |
| Q1 FY2005 | 31 Mar 2005 | 15.77B | +100.52% | 4.27B | 11.49B |
| Q4 FY2004 | 31 Dec 2004 | 15.04B | +103.86% | 4.28B | 10.77B |
| Q3 FY2004 | 30 Sept 2004 | 7.95B | +10.73% | 1.90B | 6.05B |
| Q2 FY2004 | 30 Jun 2004 | 7.53B | +5.35% | 2.09B | 5.44B |
| Q1 FY2004 | 31 Mar 2004 | 7.86B | +14.65% | 2.07B | 5.79B |
| Q4 FY2003 | 31 Dec 2003 | 7.38B | +11.09% | 2.06B | 5.32B |
| Q3 FY2003 | 30 Sept 2003 | 7.18B | +8.74% | 2.11B | 5.07B |
| Q2 FY2003 | 30 Jun 2003 | 7.15B | +53.24% | 2.04B | 5.11B |
| Q1 FY2003 | 31 Mar 2003 | 6.86B | +55.26% | 2.04B | 4.81B |
| Q4 FY2002 | 31 Dec 2002 | 6.64B | +48.34% | 1.66B | 4.98B |
| Q3 FY2002 | 30 Sept 2002 | 6.60B | +54.31% | 2.03B | 4.57B |
| Q2 FY2002 | 30 Jun 2002 | 4.67B | — | 1.12B | 3.54B |
| Q1 FY2002 | 31 Mar 2002 | 4.42B | — | 1.18B | 3.24B |
| Q4 FY2001 | 31 Dec 2001 | 4.48B | — | 1.13B | 3.35B |
| Q3 FY2001 | 30 Sept 2001 | 4.28B | — | 866.80M | 3.41B |
Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Stock buybacks,Balance sheet
Common questions about Elevance Health's cash
Source: Financial Modeling Prep